Covid-19: Covir.io, Tokenize (CVR) Biosafety licenses with Tezos Blockchain

Covir is the exclusive partner of Octupus Robots for the funding of robotic disinfection systems international licenses based on tezos blockchain. Covir is raising funds to finance the development of biosafety robots through the sale of tokens using blockchain technology.

Switzerland - April 30, 2020 /MarketersMedia/ —

Covir is the exclusive partner of Octupus Robots for the funding of robotic disinfection systems international licenses based on tezos blockchain. Covir is raising funds to finance the development of biosafety robots through the sale of tokens using blockchain technology.

Covir has recently partnered with Octopus Robots in the funding of biosafety robots through Tezos blockchain. Octopus Robots was founded in 1987 and is involved in the design of robots to perform complex tasks.

Why the choice of blockchain technology
Blockchain technology is not a new term; experts predicted blockchain technology had a little chance to survive on introduction to planet earth. More than ten years later, blockchain technology has grown beyond what anyone could ever imagine. According to Report Linker, in 2009, the global blockchain technology market size is expected to reach US$ 57,641.3 million by 2025, registering an annual growth rate of 69.4% from 2019 to 2025. The financial sector, supply chain, health care, and other industries are now employing this new technology.

Blockchain has been widely embraced because of its decentralization, immutability, transparency, and anonymity. Many are funding their blockchain wallets to escape the cruelty of government policies. More and more blockchain startups are now being created every day.

Covir owner has not been behind in this trend; that is why he decided to create a blockchain startup. Although there are many blockchain companies created, they see that blockchain startups related to biosafety robots are less represented in the industry. Covir respects the value of people. This is why they are creating a transparent and decentralized platform for them to contribute to biosafety projects without going through an intermediary.

Funding biosafety projects through tokenization
Tokenization is one of the less talked about aspects of blockchain despite its many advantages. Tokenization enables a hassle-free division of assets. Tokenization creates a company where even low-budget investors can contribute to biosafety projects. Covir has identified Tezos as a company that suites Covir objectives and, in the long run, they hope to achieve a lot together.

Why they chose Tezos for project
Covir founders thought about various available platforms that they can use to execute project. One platform kept on ringing in their mind, Tezos. Tezos is an open-source platform designed for assets and applications supported by a team of validators, researchers and builders.

Covir chose Tezos not only because they believe the platform accurately represents blockchain technology and its objectives. Its simplicity, safety and scalability are lacking in many of its peers. Tezos equally allows for flexibility as advised by Covir`s community, without any complications.

Covir project details
Covir biosafety equipment is designed to decontaminate equipment and large buildings such as; food storage facilities and airport terminals. Their unique product charges itself and delivers ultramicroscopic particles while avoiding temperature gradients and airflow, which nullify the impact of the disinfection operation. It also has an alert system in case anything goes wrong.

The token sale details
Covir token sale is divided into three periods
The private sale has started but ends on May 31, 2020. Investors are therefore advised to buy during this private sale because they get a bonus of about 30%
Up to 25% bonus ends on August 31, 2020
Up to 15% bonus, there is no deadline for this period
Very few in the world have anticipated this pandemic.

Octopus Robots is one of them, the company had already anticipated this kind of epidemic and since 2014 have planned the coup. Covir hopes that their project, with the help of investors, will help to build and distribute powerful biosafety robots for the future.

Website: https://covir.io/ & https://covir.fr/

Contact Info:
Name: Covir
Email: Send Email
Organization: Covir
Phone: 0041 7641723777
Website: https://covir.fr/en/home/

Source URL: https://marketersmedia.com/covid-19-covirio-tokenize-cvr-biosafety-licenses-with-tezos-blockchain/88955861

Source: MarketersMedia

Release ID: 88955861